Screener
10x Genomics, Inc. TXG Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s operating lease liabilities (current)?
- 10x Genomics, Inc. (TXG) reported operating lease liabilities (current) of $12.02M in Q2 2026.
- How has 10x Genomics, Inc.'s operating lease liabilities (current) changed year-over-year?
- 10x Genomics, Inc.'s operating lease liabilities (current) increased by 24.3% year-over-year, from $9.67M to $12.02M.
- What is the long-term trend for 10x Genomics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease liabilities (current) has grown at a 13.1% compound annual growth rate (CAGR), from $5.94M to $10.99M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about 10x Genomics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude